A Phase II Study of Sorafenib Combined With Cetuximab in EGFR-Expressing, KRAS-Mutated Metastatic Colorectal Cancer

Khanh Do, Liang Cao, Zhigang Kang, Baris Turkbey, Maria L. Lindenberg, Erin Larkins, Beata Holkova, Seth M. Steinberg, Mark Raffeld, Cody J. Peer, William D. Figg, Michelle Eugeni, Paula Jacobs, Peter Choyke, John J. Wright, James H. Doroshow, Shivaani Kummar^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review